Preclinical evaluation of the penciclovir analog 9-(4-[18f]fluoro-3-hydroxymethylbutyl)guanine for in vivo measurement of suicide gene expression with PET

Journal of Nuclear Medicine

Volumn 42, Issue 11, 2001, Pages 1682-1690

  Alauddin, M M ^a   Shahinian, A ^a   Gordon, E M ^a   Bading, J R ^a   Conti, P S ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

18F FHBG; Colon cancer; Gene therapy; PET; Virus

Indexed keywords

9 (4 FLUORO 3 HYDROXYMETHYLBUTYL)GUANINE F 18; FLUORINE 18; GUANINE DERIVATIVE; PENCICLOVIR; THYMIDINE KINASE; UNCLASSIFIED DRUG; VIRUS VECTOR;

ARTICLE; CANCER; COLON CANCER; CONTROLLED STUDY; GENE THERAPY; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; ISOTOPE LABELING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SUICIDE GENE;

ACYCLOVIR; ANIMALS; ANTIVIRAL AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE THERAPY; GUANINE; HT29 CELLS; HUMANS; MACACA FASCICULARIS; MALE; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; RADIOPHARMACEUTICALS; SIMPLEXVIRUS; THYMIDINE KINASE; TISSUE DISTRIBUTION;

EID: 0035209394     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Antiherpes virus activity of 9-(4-hydroxy-3-hydroxymethylbut-1-yl)guanine (BRL 39123) in cell culture
2. Metabolism of 9-(1,3-dihydroxy-2-propoxymethyl)guanine, a new anti-herpes virus compound in herpes simplex virus-infected cells
3. Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl)guanine
4. 9-[(1,3-Dihydroxy-2-propoxy)methyl] guanine: A new selective antiherpes agent
5. Intracellular metabolism and enzymatic phosphorylation of 9-(1,3-dihydroxy-2-propoxymethyl)guanine and acyclovir in herpes simplex virus infected and uninfected cells
6. Anti-herpes virus activity of the acyclic nucleoside 9-(1,3-dihydroxy-2-propoxymethyl)guanine
7. Antiherpes virus activity of 9-(4-hydroxy-3-hydroxymethylbut-1-yl)guanine (BRL 39123) in animals
8. Mode of antiviral action of penciclovir in MRC-5 cells infected with herpes simplex virus type 1 (HSV-1), HSV-2, and varicella-zoster virus
9. Synthesis and anti-herpes-virus activity of acyclic 2′-deoxyguanosine analogues related to 9-[(1,3 -dihydroxy-2-propoxy)-methyl]-guanine
10. 9-(2-Hydroxyethyloxymethyl)-guanine activity against viruses of the herpes group
11. Comparative anti-herpes-virus activities of the 9-(1,3-dihydroxy-2-propoxymethyl)guanine, acyclovir, and two 2′-fluoropyrimidine nucleosides
12. Mode of action of 9-(4-hydroxy-3-hydroxymethylbut-1-yl)guanine (BRL 39123) against herpes simplex virus in MRC-5 cells
13. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors
14. Clinical protocols: Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir
15. In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats
16. Gene therapy for cancer
17. Retroviral mediated gene therapy for the treatment of hepatocellular carcinoma: An innovative approach for cancer therapy
18. Use of tissue specific expression of the herpes simplex virus thymidine gene to inhibit growth of established murine melanomas following direct intramural injection of DNA
19. 3H-5-fluorocytosine
20. Multitracer studies during gene therapy of hepatoma cells with herpes simplex virus thymidine kinase and ganciclovir
21. Monitoring gene therapy with herpes simplex virus thymidine kinase in hepatoma cells: Uptake of specific substrates
22. 18F]-FDG in oncology: A clinical update
23. Imaging the expression of transfected genes in vivo
24. 18F]FHPG): A potential imaging agent of viral infection and gene therapy using PET
25. Pharmacokinetics of F-18 fluorohydroxy-propoxymethyl-guanine (FHPG) in primates
26. 18F]-FHBG): A new potential imaging agent for viral infection and gene therapy using PET
27. Imaging of adenoviral-directed herpes simplex virus type I thymidine kinase reporter gene expression in mice with radiolabeled ganciclovir
28. 18F]-FHPG) in vitro and in vivo as a probe for PET imaging of gene incorporation and expression in tumors
29. 18F]-FHPG)
30. 18F]-fluoro-l-hydroxy-2-propoxymethyl)guanine: A radiopharmaceutical for gene therapy
31. 18F]fluoroguanine derivatives: In vivo probes for imaging gene expression with positron emission tomography
32. Imaging adenoviral mediated therapeutic gene delivery by co-administration of a second adenovirus carrying a PET reporter gene
33. Quantitation of gene induction by PET imaging of a bi-directional tetracyclin-inducable reporter gene system in living animals
34. Tracer kinetic modeling of FHBG in mice imaged with microPET for quantitation of reporter gene expression
35. Comparison of FPCV, FHBG and FIAU as reporter probes for imaging herpes simplex virus type I thymidine kinase reporter gene expression
36. Mechanism for ganciclovir resistance in gastrointestinal tumor cells transduced with retroviral vector containing the herpes simplex virus thymidine kinase gene
37. An improved retroviral vector encoding the herpes simplex virus thymidine kinase gene in increasing antitumor efficacy in vivo
38. PET imaging of FHBG in humans: A tracer for monitoring herpes simplex virus type 1 thymidine kinase suicide gene therapy